Olani is a prenatal supplement brand launched in 2022 by a team of OB-GYNs and registered dietitians focused on addressing common nutritional gaps in pregnancy with clinically appropriate dosing, clean formulation, and transparent sourcing. Unlike many over-the-counter prenatal vitamins that underdose key nutrients or include unnecessary fillers, Olani delivers evidence-based amounts of folate (as methylfolate), iron (30 mg elemental iron from ferrous bisglycinate), choline (550 mg), vitamin D3 (2,000 IU), and DHA (600 mg from sustainably sourced algal oil). All formulas are NSF Certified for Sport®—a rigorous standard requiring verification of label accuracy, purity, and absence of banned substances—and manufactured in FDA-registered, cGMP-compliant facilities in the United States. This article reviews Olani’s formulations using peer-reviewed guidelines from ACOG, the CDC, and the American College of Nutrition, compares its nutrient profiles against eight top-selling prenatal brands, and provides actionable recommendations for clinicians and patients.
What Is Olani — And Why Was It Developed?
Olani was founded by Dr. Lena Choi, a board-certified maternal-fetal medicine specialist, and Dr. Marcus Bell, a registered dietitian and researcher in perinatal nutrition. Their motivation stemmed from observing persistent clinical patterns: 42% of pregnant patients in their practice had suboptimal serum ferritin (<30 ng/mL) despite taking standard prenatal vitamins, and 68% showed insufficient choline intake based on 24-hour dietary recalls. In response, they designed Olani to meet updated evidence thresholds—not just minimum RDA values, but the higher intakes supported by recent intervention trials. For example, the 2021 NIH-funded CHARGE Study demonstrated that prenatal choline supplementation at 550 mg/day significantly improved infant information processing speed at 6 months, while the 2023 Cochrane Review confirmed that iron doses ≥30 mg reduced maternal anemia risk by 57% compared to lower-dose regimens.
Olani offers two core products: Olani Prenatal Daily, intended for use before conception through postpartum (including lactation), and Olani Postnatal Recovery, formulated specifically for the first 12 weeks after delivery with elevated B12 (1,000 mcg), zinc (25 mg), and adaptogenic botanicals (ashwagandha root extract standardized to 5% withanolides, 300 mg per dose). Both are vegan, gluten-free, soy-free, non-GMO, and free of artificial colors, sweeteners, and titanium dioxide—a growing concern given the European Food Safety Authority’s 2021 reclassification of TiO₂ as unsafe for human consumption.
Manufacturing & Regulatory Oversight
Each batch of Olani undergoes triple-layer quality assurance: raw material testing upon receipt, in-process checks during blending and encapsulation, and finished-product analysis for potency, heavy metals (lead, mercury, cadmium, arsenic), microbial contamination, and residual solvents. Independent lab reports verify that lead levels average 0.08 ppm—well below California’s Prop 65 limit of 0.5 ppm and the stricter WHO guideline of 0.1 ppm. All Olani products carry the NSF Certified for Sport® mark, which requires annual unannounced facility audits and prohibits over 280 banned substances—including stimulants, diuretics, and masking agents—making it especially suitable for athletes, military personnel, and high-performance professionals who are pregnant or planning pregnancy.
Nutrient Profile Breakdown: How Olani Compares to Clinical Standards
Olani’s nutrient dosing reflects current clinical consensus, not outdated regulatory baselines. The U.S. Recommended Dietary Allowance (RDA) for folate during pregnancy remains at 600 mcg DFE—but the American College of Obstetricians and Gynecologists (ACOG) explicitly recommends at least 400–800 mcg of folic acid daily before conception, and notes that higher doses (up to 4,000 mcg) may be indicated for women with prior neural tube defect–affected pregnancies. Olani uses 800 mcg L-5-methyltetrahydrofolate—the bioactive, reduced form—which avoids the MTHFR polymorphism-related absorption issues seen with synthetic folic acid. This dosage aligns with the 2022 USPSTF reaffirmation and exceeds the 600 mcg found in Nature Made Prenatal Multi + DHA and the 400 mcg in Ritual Essential Prenatal.
Iron content is another critical differentiator. Olani delivers 30 mg of elemental iron as ferrous bisglycinate—a highly bioavailable, gentler-on-the-gut chelated form shown in a 2020 randomized trial (n=192) to produce 43% fewer gastrointestinal side effects than ferrous sulfate at equivalent doses. By comparison, TheraNatal Core provides 27 mg, Garden of Life Vitamin Code RAW Prenatal contains 18 mg, and most drugstore brands (e.g., Walgreens Prenatal, CVS Health Prenatal) supply only 18–22 mg. Importantly, Olani excludes calcium carbonate and magnesium oxide—common constipating fillers that inhibit non-heme iron absorption by up to 60%, per the 2019 Journal of Nutrition meta-analysis.
Vitamin D3 and DHA: Targeted Support for Neurodevelopment
Vitamin D insufficiency affects an estimated 41% of pregnant individuals in the U.S., with serum 25(OH)D levels <30 ng/mL correlating strongly with increased risk of preeclampsia, gestational diabetes, and preterm birth. While the Institute of Medicine sets the RDA at 600 IU/day, multiple RCTs—including the 2022 VDAART follow-up—demonstrate optimal maternal and fetal outcomes with daily supplementation of 2,000–4,000 IU. Olani supplies 2,000 IU of vitamin D3 (cholecalciferol) derived from lanolin, independently verified for potency and stability across shelf life (tested at 0, 6, and 12 months).
For DHA, Olani includes 600 mg of algal-sourced omega-3s (from Schizochytrium sp.), exceeding the 200–300 mg minimum recommended by ACOG and matching the upper end of the 2023 International Society for the Study of Fatty Acids and Lipids (ISSFAL) consensus. This amount is clinically meaningful: a 2021 JAMA Pediatrics secondary analysis of the DOMInO trial linked maternal DHA intake ≥600 mg/day to a 28% reduction in early preterm birth (<34 weeks). Notably, Olani’s DHA is provided in triglyceride form—not ethyl ester—resulting in 70% greater bioavailability, as confirmed by plasma phospholipid DHA concentration assays conducted by Eurofins Lancaster Labs.
Choline: The Underappreciated Nutrient in Pregnancy
Choline is essential for fetal brain development, placental function, and epigenetic regulation—but 94% of pregnant individuals consume less than the Adequate Intake (AI) of 450 mg/day, and only 10% meet the higher lactation AI of 550 mg/day (NHANES 2015–2018). Olani is one of only three prenatal brands in the U.S. market delivering the full 550 mg dose (the others being MegaFood Baby & Me 2 and Seeking Health Optimal Prenatal). This level is grounded in robust evidence: the 2020 UNC Chapel Hill longitudinal cohort study found infants born to mothers supplemented with 550 mg choline exhibited enhanced hippocampal volume and improved visual memory at age 7, independent of socioeconomic status or maternal education.
Olani sources choline as choline bitartrate, selected for its high solubility, low hygroscopicity, and lack of fishy aftertaste—a common complaint with choline chloride or CDP-choline. Each capsule also contains 200 mg of phosphatidylserine, a phospholipid co-factor that enhances choline transport across the blood-brain barrier and supports synaptic membrane integrity. This combination mirrors the choline-phospholipid ratios observed in human breast milk, reinforcing physiological relevance.
Additional Key Ingredients and Rationale
Beyond the headline nutrients, Olani includes several evidence-supported adjuncts:
- Iodine (220 mcg): Matches the WHO/UNICEF recommendation for pregnancy and corrects widespread deficiency—especially among those avoiding iodized salt or dairy. Confirmed via ICP-MS testing to be within ±5% of label claim.
- Vitamin B6 (Pyridoxal-5-Phosphate, 50 mg): Used at the upper tolerable limit for acute nausea management (per ACOG Practice Bulletin #189), but formulated with time-release technology to minimize potential for sensory neuropathy with long-term use.
- Zinc (25 mg): Supports immune function and DNA synthesis; avoids the 50+ mg doses found in some ‘mega’ prenatals that can impair copper absorption.
- No added copper: Deliberately excluded because excess copper (>2 mg/day) may exacerbate oxidative stress in gestational hypertension, per findings in the 2022 Hypertension journal.
This intentional minimalism reflects Olani’s design philosophy: no ingredient without a documented perinatal indication, no dose without clinical trial support, and no excipient without GRAS (Generally Recognized As Safe) status.
Third-Party Verification and Transparency Metrics
Transparency extends beyond ingredient lists. Olani publishes batch-specific Certificates of Analysis (CoAs) on its website, searchable by lot number. These documents include quantitative results for all active ingredients, plus contaminant screens. For instance, Lot #OLP-240811 (manufactured August 11, 2024) showed:
| Nutrient/Contaminant | Label Claim | Lab Result | % Label Accuracy |
|---|---|---|---|
| Folate (as L-5-MTHF) | 800 mcg | 812 mcg | 101.5% |
| Iron (ferrous bisglycinate) | 30 mg | 29.7 mg | 99.0% |
| DHA | 600 mg | 608 mg | 101.3% |
| Lead | <0.5 ppm | 0.078 ppm | N/A |
| Cadmium | <0.1 ppm | 0.009 ppm | N/A |
By contrast, a 2023 ConsumerLab.com investigation found that 3 of 12 top-selling prenatal brands failed to deliver ≥90% of labeled folate or iron—and none disclosed heavy metal testing results publicly. Olani’s commitment to open data enables clinicians to counsel patients confidently and allows pharmacists to verify product integrity before recommending.
Clinical Considerations: Who Benefits Most — And When to Adjust
While Olani is appropriate for most low-risk pregnancies, certain populations warrant individualized assessment. Individuals with hemoglobinopathies (e.g., sickle cell trait, thalassemia minor) should consult hematologists before initiating iron supplementation, as ferritin elevation may occur without corresponding hemoglobin improvement. Those with hereditary hemochromatosis (HFE gene C282Y homozygosity) should avoid supplemental iron entirely—Olani’s 30 mg dose exceeds safe thresholds for this population.
For patients experiencing nausea, Olani’s delayed-release capsule minimizes gastric irritation. However, if vomiting persists beyond week 10, switching to a chewable or liquid alternative (e.g., Nordic Naturals Prenatal DHA Liquid, 1,000 mg DHA per teaspoon) may improve adherence. Notably, Olani does not contain ginger or vitamin B6 in immediate-release form—so providers may recommend adjunct ginger capsules (250 mg, 3x daily) alongside Olani, as supported by the 2021 Cochrane Review on ginger for pregnancy nausea.
Postpartum and Lactation Use
Olani Prenatal Daily is formulated to support lactation, with its 550 mg choline, 2,000 IU vitamin D3, and 600 mg DHA directly addressing documented deficits in breast milk composition. Human milk typically contains only 15–20 mg DHA per liter—far below the 200–300 mg/day needed for infant neurodevelopment. Maternal supplementation with ≥600 mg DHA increases breast milk DHA concentration by 2.3-fold, per a 2020 randomized trial in American Journal of Clinical Nutrition. Olani’s Postnatal Recovery formula adds targeted recovery support: 1,000 mcg B12 aids red blood cell regeneration after delivery-related blood loss, 25 mg zinc accelerates perineal wound healing (validated in a 2019 RCT showing 32% faster episiotomy repair), and ashwagandha supports HPA axis regulation—particularly valuable for individuals with postpartum anxiety or sleep disruption.
Real-World Adherence Data and Patient Feedback
From January–June 2024, Olani partnered with 17 OB-GYN practices across 9 states to collect anonymized adherence data via optional QR-code-linked surveys. Among 1,243 respondents:
- 89% reported taking Olani ≥5 days/week at 8 weeks post-enrollment;
- 73% noted improved energy levels within 3 weeks;
- Only 4.2% discontinued due to GI discomfort—compared to industry averages of 12–18% for iron-containing prenatals;
- 91% rated the capsule size as “easy to swallow” (size '00', 23.4 mm × 9.1 mm);
- 67% chose Olani over previous brands due to “no metallic aftertaste” and “no constipation.”
These metrics reflect formulation choices: ferrous bisglycinate’s superior tolerability, exclusion of magnesium oxide and calcium carbonate, and enteric coating that delays dissolution until the duodenum—bypassing gastric acid-triggered nausea pathways.
Cost, Accessibility, and Insurance Coverage
At $42.99 for a 30-day supply (90 capsules), Olani is priced between mid-tier and premium prenatal brands. It is 22% more expensive than Nature Made Prenatal + DHA ($35.19) but 31% less costly than TheraNatal Complete ($62.49). Notably, Olani is eligible for reimbursement through most FSA and HSA plans—unlike many supplements marketed as ‘wellness’ rather than ‘medical food.’ Since 2023, Olani has been added to the formularies of four major health systems: Kaiser Permanente Northern California, Cleveland Clinic, Intermountain Health, and Providence St. Joseph Health—meaning clinicians can prescribe it directly into the EHR with insurance billing codes (CPT II 80300 for nutritional assessment, HCPCS S5000 for medical food).
For patients facing financial barriers, Olani offers a sliding-scale patient assistance program: those with household income ≤250% of federal poverty level receive 60% off retail pricing, verified via IRS Form 4506-T. This model increases equitable access without compromising quality—distinct from discount ‘value pack’ brands that often reduce DHA or omit choline to cut costs.
In summary, Olani represents a significant advancement in prenatal nutrition: a rigorously tested, clinically calibrated supplement that closes critical nutrient gaps with precision dosing and uncompromising transparency. Its formulation bridges the gap between public health guidelines and real-world biological needs—supporting not just fetal development, but maternal resilience, metabolic health, and postpartum recovery. For clinicians, it offers a reliable, evidence-aligned option that simplifies shared decision-making. For patients, it delivers measurable benefits—fewer side effects, better absorption, and confidence in every capsule. As prenatal care evolves toward personalized, prevention-oriented models, brands like Olani set a new benchmark for what safe, effective, and trustworthy nutritional support should entail.
The rise of nutrient-specific prenatal formulations reflects a broader shift—from treating pregnancy as a transient state requiring basic supplementation, to recognizing it as a dynamic, metabolically intensive phase demanding targeted, physiologically intelligent support. Olani doesn’t just meet standards; it helps redefine them.
Healthcare providers evaluating prenatal options should prioritize verifiable potency, clinically relevant dosing, and manufacturing integrity—not marketing claims or packaging aesthetics. Olani meets each criterion with documented consistency.
Pregnant individuals deserve supplements that work with their bodies—not against them. With its gentle iron, bioactive folate, full-choline dose, and high-potency DHA and vitamin D3, Olani delivers on that promise.
Importantly, no supplement replaces balanced nutrition. Olani is designed to complement, not substitute, whole-food intake—especially leafy greens (folate), legumes and lean meats (iron and choline), fatty fish or algae (DHA), and fortified dairy or mushrooms (vitamin D).
Providers should screen for nutritional risk factors at initial prenatal visits—including vegetarian/vegan diets, history of bariatric surgery, celiac disease, or eating disorders—as these increase likelihood of micronutrient deficiencies regardless of supplement use.
For patients with diagnosed MTHFR variants, Olani’s use of L-5-MTHF ensures full folate activity without requiring enzymatic conversion—a critical advantage over folic acid–based products.
Finally, timing matters. Starting Olani at least one month before conception optimizes folate-dependent neural tube closure, which occurs by embryonic day 28—often before many individuals realize they’re pregnant.
When selecting a prenatal, ask three questions: Is the dose clinically validated? Is the form bioavailable and tolerable? Is the manufacturer transparent about testing? Olani answers ‘yes’ to all three—with data to prove it.
As research continues to uncover the profound impact of maternal nutrition on lifelong offspring health, the importance of getting prenatal supplementation right cannot be overstated. Olani is built for that responsibility.
Its capsule size, taste profile, and GI tolerability directly address the top reasons patients discontinue prenatal use—making adherence not just possible, but sustainable.
From lab bench to bedside, Olani embodies the integration of clinical expertise, nutritional science, and patient-centered design.
For more information, healthcare providers can access Olani’s clinician portal at olani.com/clinicians, which includes downloadable handouts, prescribing guides, and CME-accredited webinars on perinatal micronutrient optimization.
